课题基金 / 基金详情

Analysis of Left Ventricular Remodeling and Hemodynamics in Dilated Cardiomyopathy and Myocarditis and Application for Regeneration Therapy

Analysis of Left Ventricular Remodeling and Hemodynamics in Dilated Cardiomyopathy and Myocarditis and Application for Regeneration Therapy
扩张型心肌病和心肌炎的左心室重构和血流动力学分析及再生治疗的应用
批准号:
16590678
负责人:
NISHIO Ryosuke
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

NISHIO Ryosuke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent reports have emphasized the important role of immune systems in the pathophysiology of dilated cardiomyopathy and viral myocarditis. However, the role of immune responses in left ventricular remodeling and hemodynamics of these heart diseases remain unclear. In this research, we examined the role of immune factors including cytokines in left ventricular remodeling and hemodynamics using experimental viral myocarditis. in addition, we developed new devices for regeneration therapy of this disease.Four-week-old DBA/2 mice were inoculated with encephalomyocarditis virus. In this model, myocardial lesions appear several days after viral inoculation, resulting in severe congestive heart failure. In the chronic phase, left ventricle is dilated like hearts in patients with DCM. We examined the relationship between cytokine or chemokine production and hemodynamic parameters in this animal model of viral myocarditis. We used the real-time PCR method and tissue ELISA assay. In addition, we used the Millar 1.4 Fr catheter composed of 4 conductance electrodes and a micromanometer. This catheter was advanced via the right carotid artery into left ventricle. Pressure-Volume Relationship were measured by transiently compressing the inferior vena cava. Parallel volume of each mouse was calibrated by hypertonic saline. We also measured right atrial pressure. These hemodynamic data provide new insights into the nathophysiology of viral myocarditis, and were useful in the development of therapeutic interventions.In the next series of experiments, we develop new devices, including micro-catheters and micro-balloons, for regeneration therapy.We are going to expand these new devices to clinical intervention for regeneration therapy of dilated cardiomyopathy.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-kappaB inhibitor.
新型 NF-kappaB 抑制剂可抑制细胞因子和一氧化氮的产生,并预防致命的内毒素血症和病毒性心肌炎。
DOI: --
发表时间: 2004
期刊: Eur J Heart Fail. 6
影响因子: --
作者: [Matsumori A, Nunokawa Y, Yamaki A, Yamamoto K, Hwang MW, Miyamoto T, Hara M, Nishio R, Kitaura-Inenaga K, Ono K.]
通讯作者: Ono K.
DOI: 10.1161/circulationaha.105.585182
发表时间: 2006-02-07
期刊: CIRCULATION
影响因子: 37.8
作者: [Miyamoto, S, Kawamura, T, Hasegawa, K]
通讯作者: Hasegawa, K
「進展方向が制御された細胞の培養方法」
《控制生长方向的细胞培养方法》
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: []
通讯作者:
伸展方向が制御された細胞の培養方法
一种可控延伸方向的细胞培养方法
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: []
通讯作者:
Development of new therapeutic strategies for dilated cardiomyopathy, ischemic cardiomyopathy with regenerative medicine
  • 批准号:
    24591048
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2012
  • 负责人:
    NISHIO Ryosuke
  • 依托单位:
Development of New Treatment Strategies for Viral Myocarditis and Cardiomyopathy with Lymphangiogenesis factors in the Heart
  • 批准号:
    21590892
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2009
  • 负责人:
    NISHIO Ryosuke
  • 依托单位:
海外基金